Newborn screening in Germany, Austria and Switzerland : CCCurrent status;Neugeborenenscreening in Deutschland, Österreich und der Schweiz : Aktueller Stand

Monatsschrift fur Kinderheilkunde

Volumn 157, Issue 12, 2009, Pages 1209-1214

  Lukacs, Z ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Congenital adrenal hyperplasia; Galactosemia; Hypothyreosis; Newborn screening; Tandem mass spectrometry

Indexed keywords

AUSTRIA; BIOTINIDASE DEFICIENCY; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL DISORDER; FATTY ACID OXIDATION; GALACTOSEMIA; GERMANY; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HYPOTHYROIDISM; METABOLIC DISORDER; NEWBORN SCREENING; OUTCOME ASSESSMENT; PHENYLKETONURIA; PRACTICE GUIDELINE; REVIEW; SWITZERLAND; TANDEM MASS SPECTROMETRY;

EID: 77249099232     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-009-2041-7     Document Type: Review

References (18)

1. American College of Medical Genetics Newborn Screening Expert Group (2006) Newborn scree¬ning: toward a uniform screening panel and sys¬tem - executive summary. Pediatrics 117(5 Pt 2):S296-S307
2. Barben J, Torresani T, Schöni MH et al (2008) Neu¬geborenen- Screening auf zystische Fibrose - bald auch in der Schweiz? Paediatrica 19:22-23
3. Bodamer O (2008) Gescreenter Start ins Leben. Ös¬terreich Ärztez 5:52-56
4. Bodamer OA, Hoffmann GF, Lindner M (2007) Ex¬panded newborn screening in Europe. J Inherit Metab Dis 30:439-444
5. Botkin JR, Clayton EW, Fost NC et al (2006) New¬born screening technology: proceed with caution. Pediatrics 117:1793-1799
6. Folling A (1934) Über Ausscheidung von Phenyl¬ brenztraubensäure in den Harn als Stoffwechsela¬nomalie in Verbindung mit Imbezillität. Z Physiol Chem 227:169-176
7. Gemeinsamer Bundesausschuss der Ärzte und Krankenkassen (2005) Beschluss über eine Ände¬rung der Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Früherken¬nung von Krankheiten bei Kindern bis zur Vollen¬dung des 6. Lebensjahres (Kinder-Richtlinien) zur Einführung des erweiterten Neugeborenen-Scree¬nings. Dtsch Ärztebl 10:1158-1163
8. Guthrie R, Susie A (1963) A simple phenylalanine method for detecting phenylketonuria in large po¬pulations of newborn infants. Pediatrics 32:338-343
9. Höpfner S, Höpfner B, Rauterberg EW (2005) Neo¬natal screening for congenital hypothyroidism in Hessen, Germany: efficiency of the screening pro¬gram and school achievement of 129 children at an age of 8-12 years. J Perinat Med 33:543-548
10. Liebl B, Fingerhut R, Röschinger W et al (2000) Mo¬del project for updating neonatal screening in Ba¬varia: concept and initial results. Gesundheitswe¬sen 62:189-195
11. Lukacs Z, Santer R (2006) Evaluation of electro¬spray-tandem mass spectrometry for the detec¬tion of phenylketonuria and other rare disorders. Mol Nutr Food Res 50:443-450
12. Matern D, Tortorelli S, Oglesbee D et al (2007) Re¬duction of false-positive rate in newborn scree¬ning by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis 30:585-592
13. Natowicz M (2005) Newborn screening - setting evidence-based policy for protection. N Engl J Med 353:867-870
14. Schulze A, Lindner M, Kohlmüller D et al (2003) Ex¬panded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome and implica¬tions. Pediatrics 111:1399-1406
15. Therrell BL, Adams J (2007) Newborn screening in North America. J Inherit Metab Dis 30:447-465
16. Torresani T, Steinmann B (2007) Jahresbericht 2006: Neugeborenen- Screening in der Schweiz. Paediatrica 18:56
17. Wilson JMG, Jungner G (1968) Public health pa¬pers no. 34. World Health Organization, Geneva
18. Zytkovicz TH, Fitzgerald EF, Marsden D et al (2001) Tandem mass spectrometry analysis for amino, or¬ganic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the new England newborn screening program. Clin Chem 47:1945-1955